These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 18056168

  • 21. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 22. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005 Apr; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 23. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer.
    Kawaguchi T, Sho M, Tojo T, Yamato I, Nomi T, Hotta K, Hamada K, Suzaki Y, Sugiura S, Kushibe K, Nakajima Y, Taniguchi S.
    Jpn J Clin Oncol; 2010 Apr; 40(4):319-26. PubMed ID: 20085909
    [Abstract] [Full Text] [Related]

  • 24. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 25. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
    Zhang Y, Huang D, Yu G.
    Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
    Krysan K, Dalwadi H, Sharma S, Põld M, Dubinett S.
    Cancer Res; 2004 Sep 15; 64(18):6359-62. PubMed ID: 15374938
    [Abstract] [Full Text] [Related]

  • 27. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
    Fan J, Wang L, Jiang GN, He WX, Ding JA.
    Lung Cancer; 2008 Jul 15; 61(1):91-6. PubMed ID: 18192073
    [Abstract] [Full Text] [Related]

  • 28. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FA, Pinedo HM, van Tinteren H, Giaccone G.
    Clin Cancer Res; 2001 Aug 15; 7(8):2468-74. PubMed ID: 11489828
    [Abstract] [Full Text] [Related]

  • 29. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Cancer Res; 2001 Mar 15; 61(6):2500-4. PubMed ID: 11289121
    [Abstract] [Full Text] [Related]

  • 30. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H, Tanaka F.
    Lung Cancer; 2006 Jan 15; 51(1):79-88. PubMed ID: 16225959
    [Abstract] [Full Text] [Related]

  • 31. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    Apostolopoulou K, Pateras IS, Evangelou K, Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A, Cordon-Cardo C, Gorgoulis VG.
    J Pathol; 2007 Nov 15; 213(3):294-302. PubMed ID: 17907153
    [Abstract] [Full Text] [Related]

  • 32. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY.
    Pathol Int; 2006 Sep 15; 56(9):503-9. PubMed ID: 16930330
    [Abstract] [Full Text] [Related]

  • 33. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 15; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 34. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer.
    Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B.
    J Cancer Res Clin Oncol; 2002 Oct 15; 128(10):554-60. PubMed ID: 12384799
    [Abstract] [Full Text] [Related]

  • 35. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 36. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI.
    Clin Cancer Res; 2007 Feb 01; 13(3):884-91. PubMed ID: 17289881
    [Abstract] [Full Text] [Related]

  • 37. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F.
    Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189
    [Abstract] [Full Text] [Related]

  • 38. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, Kamei M, Takeno S, Kawahara K.
    Anticancer Res; 2007 Feb 01; 27(4C):2803-8. PubMed ID: 17695451
    [Abstract] [Full Text] [Related]

  • 39. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
    Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M, Scagliotti GV.
    Cancer; 2006 Oct 01; 107(7):1589-96. PubMed ID: 16955506
    [Abstract] [Full Text] [Related]

  • 40. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S.
    Oncol Rep; 2004 Dec 01; 12(6):1189-94. PubMed ID: 15547736
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.